Interferon-ε is a tumour suppressor and restricts ovarian cancer
Zoe R. C. Marks, Nicole K. Campbell, Niamh E. Mangan, Cassandra J. Vandenberg, Linden J. Gearing, Antony Y. Matthews, Jodee A. Gould, Michelle D. Tate, Georgie Wray‐McCann, Le Ying, Sarah Rosli, Natasha K. Brockwell, Belinda S. Parker, San Sui Lim, Maree Bilandzic, Elizabeth L. Christie, Andrew N. Stephens, Eveline D. de Geus, Matthew J. Wakefield, Gwo‐Yaw Ho, Orla McNally, Australian Ovarian Cancer Study, David D.L. Bowtell, Penelope M. Webb, Anna DeFazio, Nadia Traficante, Sián Fereday, Leanne Bowes, Joy Hendley, Iain A. McNeish, David D.L. Bowtell, Nicole A. de Weerd, Clare L. Scott, Nollaig M. Bourke, Paul J. Hertzog
Topics & Concepts
Ovarian cancerCancer researchSerous fluidBiologyInterferonMyeloid-derived Suppressor CellCancerImmunologySuppressorMedicineBiochemistryGeneticsOvarian cancer diagnosis and treatmentImmune Cell Function and InteractionCancer-related molecular mechanisms research